x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Oprah"s Weight Loss Dilemma: The Ozempic

Inception Point Ai

Join us on "The Oprah Ozempic Odyssey," where we explore the intriguing world of weight loss through the lens of Oprah Winfrey"s recent remarks about the weight loss drug, Ozempic. Dive into the heated debate surrounding the use of weight loss drugs, and discover the pros and cons of Ozempic as we break down its potential benefits and side effects. Through thoughtful discussions and a touch of humor, we help you navigate this complex topic, providing insights and considerations to make informed

health & fitness medicine

All Episodes

2:06

AI Bias Tools and Security Risks Emerge as Developers...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/04/22

Recent studies from Penn State University highlight a new inclusive prompt coaching tool designed for artificial intelligence text-to-image generators. This tool, developed by researchers including those from Penn State and Oregon State University, alerts users to potential biases in their prompts before images are created. For instance, if someone enters a prompt like beautiful girls in the forest, the system warns that it may reinforce stereotypes about female beauty tied to physical appearance,

en

2:09

Ozempic Weight Loss Updates April 2026: Doctors...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/04/18

Recent reports from the past week highlight ongoing discussions around Ozempic and its role in weight loss, though no major new breakthroughs emerged between April 11 and April 18, 2026. According to health news outlets like CNN Health and WebMD updates, doctors continue to prescribe semaglutide-based drugs such as Ozempic for obesity management, emphasizing sustainable lifestyle changes alongside medication to combat side effects like nausea and muscle loss. A study referenced in The New York Times

en

2:37

Ozempic Shortage Crisis 2026 Demand Surges as Novo...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/04/11

Recent reports from this past week highlight growing concerns over the supply shortages of Ozempic, the popular weight loss drug from Novo Nordisk. According to Bloomberg on April 8, 2026, pharmacies across the United States are facing empty shelves due to surging demand, with patients turning to compounded versions that lack full regulatory approval. This shortage stems from manufacturing delays and an overwhelming number of prescriptions for off-label weight loss use, even as the drug is primarily

en

3:05

Florida Law Enforcement Warns Against AI Deepfake...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/04/08

In the past week, law enforcement in Florida has issued urgent warnings about a dangerous new prank involving artificial intelligence-generated fake crime videos. According to the Orange County Sheriffs Office, these deepfake videos depict realistic scenes of crimes in progress, tricking officers into real responses. In one case, a person showed a deputy a video appearing to show someone breaking into the officers squad car, prompting an immediate reaction with the deputy placing a hand on his

en

2:03

Ozempic Dominates Obesity Treatment with Two Million...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/04/04

In the past week, discussions around Ozempic and weight loss have heated up among listeners tuning into health news. According to Bloomberg News on March 30, 2026, new data from the Food and Drug Administration shows Ozempic, the popular semaglutide injection from Novo Nordisk, continues to dominate prescriptions for obesity treatment, with over two million new users reported in the first quarter alone. This surge follows clinical trials confirming sustained weight loss of up to twenty percent in

en

2:12

Ozempic Policy Debate Heats Up in Minnesota as...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/04/01

In the past week, discussions around Ozempic and weight loss drugs have intensified, blending policy debates with celebrity health rumors. Minnesota lawmakers grappled with costs in the House Health Finance and Policy Committee, where a bill, HF4142, sponsored by Representative something, aimed to prohibit Medical Assistance coverage for prescription drugs used solely for weight loss like Ozempic. The measure was laid over, sparking questions on whether funding these medications saves money

en

2:27

Ozempic Shows Mental Health Benefits but Poses Risks...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/03/28

Recent studies from the past week highlight new insights into Ozempic and similar GLP-1 medications for weight loss. Researchers from the University of Eastern Finland, Karolinska Institutet in Stockholm, and Griffith University in Australia analyzed large-scale data and found that semaglutide, the active ingredient in Ozempic, significantly reduces risks of depression, anxiety, and addiction alongside its weight loss effects. According to their work published in The Lancet Psychiatry, users

en

2:43

GLP-1 Drugs Like Ozempic Show Promise for Weight...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/03/25

A new study from the Cleveland Clinic, released this week, reveals that stopping weight-loss drugs like Ozempic and Mounjaro does not always lead to the rapid weight regain seen in earlier trials. Researchers analyzed nearly eight thousand patients who discontinued these injectable medications, known as GLP-one drugs, after using them for obesity or type two diabetes. Those treated for obesity lost an average of eight point four percent of their body weight before stopping and regained just zero

en

3:13

Cleveland Clinic Study Shows Less Weight Regain After...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/03/21

Recent research from Cleveland Clinic is challenging what many people thought they knew about stopping weight loss medications like Ozempic and Wegovy. A new study published in the journal Diabetes, Obesity and Metabolism analyzed nearly eight thousand patients who used semaglutide or tirzepatide for three to twelve months before discontinuing treatment. The findings offer surprising hope compared to earlier clinical trials that suggested dramatic weight regain after stopping these drugs.In the real

en

2:39

Ozempic Weight Loss Study Shows 75 Percent Regain...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/03/18

A recent analysis from the University of Cambridge, published in eClinicalMedicine, reveals that people stopping Ozempic-like drugs such as semaglutide and tirzepatide retain about twenty-five percent of their lost weight up to one year later. However, researchers note a key uncertainty: much of the weight loss during treatment, potentially forty to sixty percent, may come from lean muscle mass rather than fat, and it remains unclear if regained weight restores muscle proportionately. The study,

en

2:30

GLP-1 Drug Switching Common in First Year, Study...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/03/14

A new study from UT Southwestern Medical Center, reported by HealthDay News on March 12, reveals that people often switch between GLP-1 weight-loss drugs like Ozempic and Zepbound within the first year of treatment. Researchers analyzed insurance claims from nearly 127,000 overweight or obese adults who started these medications between 2019 and 2024. Only a quarter stayed on their initial drug for a full year, with about one in five switching due to side effects, access issues, or insurance

en

4:32

Ozempic and Weight Loss Drugs Reshape Health...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/03/07

Ozempic and similar weight loss drugs have dominated health headlines again this week, and much of the conversation is circling around how these medications are reshaping expectations about body size, long term health, and even celebrity image. Ozempic, whose generic name is semaglutide, is part of a class of drugs called glucagon like peptide one receptor agonists that were first approved to help people with type two diabetes manage blood sugar. In recent years doctors have also prescribed them for

en

2:56

GLP One Drugs Transform Weight Loss and Diabetes...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/03/04

The landscape of weight loss medications is evolving rapidly. Just this week, Health Canada approved an expanded indication for Ozempic, semaglutide injection, to reduce the risk of major adverse cardiovascular events in adults with type two diabetes who have established cardiovascular disease or chronic kidney disease. This approval comes based on positive outcomes from multiple clinical trials including SUSTAIN 6, PIONEER 6, FLOW and SOUL, marking an important advancement in how these medications

en

2:51

Novo Nordisk Slashes Wegovy and Ozempic Prices Up to...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/02/28

The weight loss drug market is undergoing a dramatic transformation this week as Novo Nordisk announced major price cuts for its popular medications Ozempic and Wegovy. Starting January 2027, the Danish pharmaceutical company will reduce prices by up to 50 percent for Wegovy and 35 percent for Ozempic, with both medications selling for 675 dollars per month. This announcement reflects intensifying competition in the GLP-1 drug market, where Eli Lilly's Mounjaro and Zepbound have been aggressively

en

2:39

Novo Nordisk Cuts Ozempic and Wegovy Prices Up to...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/02/25

Novo Nordisk announced on Tuesday that it plans to cut the list prices of its blockbuster weight-loss and diabetes drugs Ozempic and Wegovy by up to fifty percent starting January first, twenty twenty-seven. The Danish company stated that various doses of these medications, which contain the active ingredient semaglutide, will drop to six hundred seventy-five dollars per month. This represents a fifty percent reduction for Wegovy and a thirty-five percent cut for Ozempic, with the same price

en

2:18

Ozempic MDL Reaches 3000 Cases Over Side Effects...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/02/21

Recent developments in the Ozempic multidistrict litigation highlight growing concerns over side effects from the popular weight loss drug. Lawsuit Information Center reports that as of early February 2026, the MDL includes over three thousand pending cases, with a status conference on February tenth addressing case management, plaintiff fact sheets, and discovery timelines. Plaintiffs allege that Novo Nordisk failed to adequately warn about risks like gastroparesis, or stomach paralysis, and

en

2:36

GLP-1 Weight Loss Drugs Ozempic and Mounjaro Show 11...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/02/18

Recent Cochrane reviews commissioned by the World Health Organization show that blockbuster weight loss drugs like Ozempic deliver substantial results. According to ScienceDaily reporting on February 11, these GLP-1 drugs, including semaglutide in Ozempic and tirzepatide in Mounjaro, lead to average weight losses of 11 to 16 percent over one to two years in people with obesity, far outperforming placebos in trials with thousands of participants. Tirzepatide achieved about 16 percent reduction after

en

3:02

GLP-1 Weight Loss Drugs Show Promise: Semaglutide and...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/02/14

Recent news highlights ongoing developments in weight loss treatments like Ozempic, with fresh insights from clinical reviews and patient experiences. On February 11, 2026, Cochrane reviews commissioned by the World Health Organization analyzed GLP-1 drugs including semaglutide, sold as Ozempic and Wegovy. These studies, drawing from dozens of trials with tens of thousands of participants, show semaglutide leads to an average weight loss of about 11 percent after six to 18 months when paired with

en

2:19

Ozempic and Wegovy Weight Loss: Benefits, Risks, and...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/02/11

Recent research from the University of Cambridge highlights a key concern with popular weight-loss drugs like Ozempic and Wegovy. These medications sharply reduce appetite, leading to calorie intake dropping by sixteen to thirty-nine percent, which drives effective weight loss for people with obesity. However, experts from University College London and the University of Cambridge warn that many users lack proper nutrition guidance, risking muscle loss of up to forty percent of total weight shed and

en

2:52

GLP-1 Drugs Like Ozempic Transform Weight Loss...

Oprah"s Weight Loss Dilemma: The Ozempic ·

2026/02/07

In the past week, weight loss drugs like Ozempic, Wegovy, and Mounjaro have reshaped global conversations on obesity, marking 2026 as a potential turning point. Firstpost reports that these GLP-1 drugs, originally developed for type two diabetes, trigger significant weight loss by curbing appetite, leading to falling obesity rates in the United States for the first time since the 1980s. One in eight Americans now uses these medications, sparking changes across industries. Supermarkets see snack

en

74 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown